e-learning
resources
Munich 2006
Tuesday 05.09.2006
Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of DOTS strategy on new confirmed tuberculosis
D. S. Zivkovic, M. M. Zivkovic, M. M. Radovic, S. M. Golubovic, L. Ristic, M. H. Rancic, T. N. Pejcic, I. J. Stankovic (Nis, Serbia And Montenegro)
Source:
Annual Congress 2006 - Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Session:
Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Session type:
Poster Discussion
Number:
3447
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. S. Zivkovic, M. M. Zivkovic, M. M. Radovic, S. M. Golubovic, L. Ristic, M. H. Rancic, T. N. Pejcic, I. J. Stankovic (Nis, Serbia And Montenegro). Effects of DOTS strategy on new confirmed tuberculosis. Eur Respir J 2006; 28: Suppl. 50, 3447
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
The WHO-recommended strategy of tuberculosis control: the new vision of DOTS
Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?
Year: 2007
Efficiency of the tuberculosis detection in the implantation of the DOTS program
Source: Eur Respir J 2007; 30: Suppl. 51, 422s
Year: 2007
Impact of applying the DOTS strategy on the TB endemic evolution in Bucharest
Source: Eur Respir J 2007; 30: Suppl. 51, 422s
Year: 2007
Drug resistance in previously treated patients of tuberculosis in pre DOTS and DOTS era and its implications
Source: Annual Congress 2009 - Tuberculosis control
Year: 2009
New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002
A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Population of bacteria in treatment of patients with tuberculosis by DOTS method
Source: Eur Respir J 2001; 18: Suppl. 33, 175s
Year: 2001
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Evolution of the strategies for control and elimination of tuberculosis
Source: Eur Respir Monogr 2018; 82: 36-61
Year: 2018
Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011
Evolution of TB control and elimination strategies
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB
Source: Eur Respir J 2007; 30: Suppl. 51, 658s
Year: 2007
Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008
Results of the treatment of relapses of tuberculosis by DOTS method
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001
Investing in a novel shorter treatment regimen for multidrug-resistant tuberculosis: to be repeated
Source: Eur Respir J , 49 (3) 1700081; DOI: 10.1183/13993003.00081-2017
Year: 2017
Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme
Source: Annual Congress 2010 - Tuberculosis epidemiology
Year: 2010
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Source: Eur Respir J 2012; 39: 626-634
Year: 2012
Peculiarities in implementation of national tuberculosis program in patients with smear negative pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept